148 related articles for article (PubMed ID: 37645409)
1. Clinical characteristics and acute complication of COVID-19 patients with diabetes: a multicenter, retrospective study in Southern China.
Zhou XY; Huang SF; Lin JX; Zhi HN; Xiao L; Wang XZ; Guo KH; Zhou L; Long T; You HM; Lin MR; Luo XY; Sun WP; Zeng CP
Front Endocrinol (Lausanne); 2023; 14():1237832. PubMed ID: 37645409
[TBL] [Abstract][Full Text] [Related]
2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
3. Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey.
Qin S; Li Y; Wang L; Zhao X; Ma X; Gao GF
Emerg Microbes Infect; 2023 Dec; 12(2):2258232. PubMed ID: 37691586
[TBL] [Abstract][Full Text] [Related]
4. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
6. Neurological symptoms and comorbidity profile of hospitalized patients with COVID-19.
Cremaschi RC; Bahi CAS; Paola AAV; Arakaki JSO; Ferreira PRA; Bellei NCJ; Borges V; Coelho FMS
Arq Neuropsiquiatr; 2023 Feb; 81(2):146-154. PubMed ID: 36948200
[TBL] [Abstract][Full Text] [Related]
7. Prospective Study in 355 Patients With Suspected COVID-19 Infection: Value of Cough, Subjective Hyposmia, and Hypogeusia.
Martin-Sanz E; Riestra J; Yebra L; Larran A; Mancino F; Yanes-Diaz J; Garrote M; Colmenero M; Montiel E; Molina C; Moreno D; Rodriguez A; Monedero G; Sanz-Fernández R; Gonzalez R; Esteban-Sanchez J
Laryngoscope; 2020 Nov; 130(11):2674-2679. PubMed ID: 32686164
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of coronavirus disease 2019 infections among diabetics: A retrospective and multicenter study in China.
Yi H; Lu F; Jin X; Chen R; Liu B; Dong X; Xiong W; Yang D; Guo Y; Zhou M
J Diabetes; 2020 Dec; 12(12):919-928. PubMed ID: 32725691
[TBL] [Abstract][Full Text] [Related]
10. Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes.
Chen X; Chen Y; Wu C; Wei M; Xu J; Chao YC; Song J; Hou D; Zhang Y; Du C; Li X; Song Y
BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33214191
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
[TBL] [Abstract][Full Text] [Related]
12. Case Report: COVID-19 Patient With Chief Complaint of Anosmia and Ageusia; a Unique Perspective on Atypical Symptomatology and Management in the Military.
Smith LTAC; Hodges CDRJ; Pratt M; Porter IM
Mil Med; 2020 Dec; 185(11-12):e2176-e2179. PubMed ID: 32776115
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes.
Al Hayek AA; Robert AA; Alotaibi ZK; Al Dawish M
Diabetes Metab Syndr; 2020; 14(6):1841-1845. PubMed ID: 32971511
[TBL] [Abstract][Full Text] [Related]
14. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection.
Özçelik Korkmaz M; Eğilmez OK; Özçelik MA; Güven M
Eur Arch Otorhinolaryngol; 2021 May; 278(5):1675-1685. PubMed ID: 33011957
[TBL] [Abstract][Full Text] [Related]
15. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19.
Boytsov SA; Pogosova NV; Paleev FN; Ezhov MV; Komarov AL; Pevsner DV; Gruzdev KA; Barinova IV; Suvorov AY; Alekseeva IA; Milko OV
Kardiologiia; 2021 Mar; 61(2):4-14. PubMed ID: 33734042
[TBL] [Abstract][Full Text] [Related]
17. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data.
Dell'Aquila K; Lee J; Wang SH; Alamuri TT; Jennings R; Tang H; Mahesh S; Leong TJ; Fleysher R; Henninger EM; Veeraraghavan S; Mirhaji P; Hou W; Herold KC; Duong TQ
Diabetes Obes Metab; 2023 Sep; 25(9):2482-2494. PubMed ID: 37254311
[TBL] [Abstract][Full Text] [Related]
18. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
[TBL] [Abstract][Full Text] [Related]
19. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
20. Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection.
Púa Torrejón RC; Ordoño Saiz MV; González Alguacil E; Furones García M; Cantarín Extremera V; Ruiz Falcó ML; Soto Insuga V
Pediatr Neurol; 2022 Nov; 136():28-33. PubMed ID: 36084419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
